Lymph node yield as a measure of pancreatic cancer surgery quality

Lymph node yield as a measure of pancreatic cancer surgery quality

Introduction: Evaluated lymph node (ELN) yield has been established as a promising measure of surgical quality. Research has suggested that an ELN of at least 15 in pancreatic cancer patients is associated with improved survival and staging metrics. The aim of this study was to determine what impact...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery in practice and science 2022-09, Vol.10, p.100103, Article 100103
Hauptverfasser: Zhao, Kevin, Fatunmbi, Ayobami, Wang, Shengxuan, Young, Katelyn, Hoffman, Rebecca L., Blansfield, Joseph A.
Format: Artikel
Sprache:eng
Schlagworte:
Evaluated lymph node yield
Lymph node harvest
Neoadjuvant therapy
Pancreatic adenocarcinoma
Perioperative outcomes
Surgical quality improvement
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Evaluated lymph node (ELN) yield has been established as a promising measure of surgical quality. Research has suggested that an ELN of at least 15 in pancreatic cancer patients is associated with improved survival and staging metrics. The aim of this study was to determine what impact a high ELN yield of ≥15 has in a novel population. Methods: A retrospective cohort study was performed of patients with resectable, non-metastatic pancreatic adenocarcinoma who underwent neoadjuvant therapy followed by pancreatectomy using the National Cancer Database (NCDB 2004-2017). Patients who had
ISSN:2666-2620
2666-2620
DOI:10.1016/j.sipas.2022.100103